|国家科技期刊平台
首页|期刊导航|临床医学工程|肺力咳合剂联合氨溴索在支气管炎患儿中的应用效果

肺力咳合剂联合氨溴索在支气管炎患儿中的应用效果OA

Application Effect of Feilike Mixture Combined with Ambroxol in Children with Bronchitis

中文摘要英文摘要

目的 探讨肺力咳合剂联合氨溴索在支气管炎患儿中的应用效果.方法 将2021年5月至2022年5月我院收治的90例支气管炎患儿随机分为两组.对照组采用氨溴索治疗,研究组在对照组基础上采用肺力咳合剂治疗,对比两组的临床疗效、血清炎性因子水平、肺功能指标、免疫功能指标和不良反应发生率.结果 研究组总有效率为95.56%,高于对照组的80.00%(P<0.05).治疗后,研究组的CRP、PCT、TNF-α水平低于对照组,FEV1、FVC、FEV1/FVC及IgM、IgA、IgG水平高于对照组(P<0.05).两组均未出现严重不良反应.结论 肺力咳合剂联合氨溴索治疗支气管炎患儿的效果显著,可有效改善其肺功能,抑制炎性反应,增强机体免疫力,且用药不良反应较少.

Objective To explore the application effect of Feilike mixture combined with ambroxol in children with bronchitis.Methods 90 children with bronchitis admitted to our hospital from May 2021 to May 2022 were randomly divided into two groups.The control group was treated with ambroxol,and the study group was treated with Feilike mixture on the basis of the control group.The clinical efficacy,serum inflammatory factor levels,lung function indicators,immune function indicators,and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the study group was 95.56%,higher than 80.00%of the control group(P<0.05).After treatment,the CRP,PCT and TNF-α levels of the study group were lower than those of the control group,and the FEV1,FVC,FEV1/FVC,IgM,IgA and IgG levels were higher than those of the control group(P<0.05).Both groups did not have serious adverse reactions.Conclusions Feilike mixture combined with ambroxol has significant effect in the treatment of children with bronchitis,which can improve the lung function,inhibit the inflammatory reaction,and enhance the body immunity,with fewer adverse reactions.

苏建昌;闫利霞;贺兵兵

洛阳市东方人民医院儿科病区,河南洛阳 471003

临床医学

支气管炎肺力咳合剂氨溴索炎性因子肺功能免疫功能

BronchitisFeilike mixtureAmbroxolInflammatory factorLung functionImmune function

《临床医学工程》 2024 (003)

289-290 / 2

10.3969/j.issn.1674-4659.2024.03.0289

评论